Epidemiology and detection of molecular biomarkers in cancer: diagnosis, prognosis and response to treatment.
Basic/translational research
University of Barcelona - Catalan Institute of Oncology (ICO)
·Barcelona ·

The group focuses its research on genetic epidemiology, molecular diagnosis of cancer, prognostic markers, prediction of therapeutic response and identification of new therapeutic targets. In addition, they provide comprehensive assistance to oncology patients from a multidisciplinary approach (assessment, treatment, evolution, follow-up).

The team’s projects of interest include IMAGene (https://www.imagene.ieo.eu/), which aims to identify biomarkers for the follow-up of people at high risk of pancreatic cancer, and MicroPanc, which seeks to evaluate the role of the microbiome in pancreatic cancer. Also the development of predictive models based on artificial intelligence techniques to predict oncological outcomes.

Main publications in pancreatic cancer:

  1. Porta M, Gasull M, Pumarega J, et al. Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 2022;51 (2):479-490. doi: 10.1093/ije/dyab115
  2. Lindström S, Wang L, Feng H, et al. Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. J Natl Cancer Inst. 2023 Mar 17:djad043. doi: 10.1093/jnci/djad043.
  3. Zhu J, Shu X, Guo X, et al. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1501-1508. doi: 10.1158/1055-9965.EPI-20-0091. 
Victor Moreno

Principal Investigator

Group members

  • Mireia Obón-Santacana
  • Alex Teulé
  • Luis Salvador
  • Eric Duell
  • Silvia Murcia

Other groups

Angiogenesis Group – Alfredo Martínez Ramírez

The Angiogenesis Group is part of the Oncology Area of the Biomedical Research Center of La Rioja (CIBIR), located in Logroño, Spain. As the name implies, the Angiogenesis Group focuses on the process of angiogenesis in relation to cancer and other relevant diseases...